Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 50 of 1294 entries
View as:

Bleed Free Treatment of Menopausal Symptoms With New Ultra Low Dose Hormonal Combinations

Phase: N/A Priority: Normal
NCT ID: NCT00184795 Org: User:
Start: 05/28/04 End: 05/04/05 Due: 05/04/06

A Study to Look at How Safe NNC0268-0965 is in Healthy People and People With Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT03965013 Org: User:
Start: 06/05/19 End: 12/14/19 Due: 12/14/20

A Study Comparing the Injection Site Pain Experience After the Injection of 2 Different Solutions of Semaglutide With 2 Different Injection Pens, a Compound for the Treatment of Type 2 Diabetes and Obesity

Phase: N/A Priority: Normal
NCT ID: NCT04007107 Org: User:
Start: 06/27/19 End: 09/04/19 Due: 09/04/20

Research Study in Japan to Compare Dasiglucagon With Glucagon in Treating Very Low Levels of Blood Sugar in Asian Adults With Type 1 Diabetes and Testing of Dasiglucagon for the Same Condition in Japanese Adolescents

Phase: N/A Priority: Normal
NCT ID: NCT06588504 Org: User:
Start: 09/10/24 End: 08/13/25 Due: 08/13/26

Comparison of NPH Insulin and Insulin Detemir in Children and Adolescents With Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00435019 Org: User:
Start: 02/28/07 End: 09/30/08 Due: 09/30/09

A Trial Investigating the Pharmacokinetics and Pharmacodynamics of NNC0123-0000-0338 in a Tablet Formulation With Three Different Coatings in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01931137 Org: User:
Start: 08/31/13 End: 12/31/13 Due: 12/31/14

Comparison of the Effect of NN5401 With the Effect of NN1250 and Insulin Aspart in Subjects With Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01173926 Org: User:
Start: 07/31/10 End: 11/30/10 Due: 11/30/11

Persons With Obesity (PwO) Exploratory Research

Phase: N/A Priority: Normal
NCT ID: NCT05736120 Org: User:
Start: 02/19/23 End: 04/19/23 Due: 04/19/24

Comparing Efficacy and Safety of Thrice Daily Versus Twice Daily NovoMix® 30 (Biphasic Insulin Aspart 30) in Subjects With Type 2 Diabetes Inadequately Controlled With Basal Insulin

Phase: N/A Priority: Normal
NCT ID: NCT02582242 Org: User:
Start: 10/19/15 End: 04/18/17 Due: 04/18/18

Growth Hormone Treatment in Infants Aged 1 to 2 Years With Chronic Renal Insufficiency (CRI) and Growth Retardation.

Phase: N/A Priority: Normal
NCT ID: NCT00184769 Org: User:
Start: 01/29/98 End: 12/21/05 Due: 12/21/06

Recombinant Factor VIIa in Acute Intracerebral Haemorrhage

Phase: N/A Priority: Normal
NCT ID: NCT00127283 Org: User:
Start: 05/31/05 End: 01/31/07 Due: 01/31/08

Investigating the Effectiveness of Tresiba® (Insulin Degludec) After Switching Basal Insulin in a Population With Type 1 or Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT02662114 Org: User:
Start: 12/08/15 End: 08/12/16 Due: 08/12/17

Effect of rIL-21 on Metastases in Lymph Nodes in Melanoma Skin Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00601861 Org: User:
Start: 02/13/08 End: 06/25/08 Due: 06/25/09

A Research Study, Looking at How Tresiba® Works in People With Type 2 Diabetes in Local Clinical Practice in Russia

Phase: N/A Priority: Normal
NCT ID: NCT04315688 Org: User:
Start: 03/30/20 End: 08/02/21 Due: 08/02/22

An Observational Study on Efficacy and Safety in Subjects Using Levemir® for the Treatment of Insulin Dependent Type 1 or Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00738153 Org: User:
Start: 06/30/08 End: 05/31/09 Due: 05/31/10

Safety, Efficacy and Pharmacokinetics of NNC-0156-0000-0009 in Previously Treated Children With Haemophilia B.

Phase: N/A Priority: Normal
NCT ID: NCT01467427 Org: User:
Start: 05/16/12 End: 11/17/23 Due: 11/17/24

A Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart and BIAsp 30 in Insulin naïve Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01513590 Org: User:
Start: 01/16/12 End: 11/19/12 Due: 11/19/13

Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 2 Diabetes Mellitus When Failing on OADs

Phase: N/A Priority: Normal
NCT ID: NCT00537277 Org: User:
Start: 10/31/07 End: 01/31/09 Due: 01/31/10

A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in Italy, as Part of Local Clinical Practice

Phase: N/A Priority: Normal
NCT ID: NCT04094415 Org: User:
Start: 10/28/19 End: 07/28/21 Due: 07/28/22

Trial to Evaluate Reduction in Inflammation in Patients With Advanced Chronic Renal Disease Utilizing Antibody Mediated IL-6 Inhibition in Japan.

Phase: N/A Priority: Normal
NCT ID: NCT04626505 Org: User:
Start: 10/22/20 End: 09/28/21 Due: 09/28/22

Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01068665 Org: User:
Start: 03/31/10 End: 11/30/10 Due: 11/30/11

Norditropin NordiFlex® Device Compared to the Device Previously Used by Patients or Parents

Phase: N/A Priority: Normal
NCT ID: NCT01245374 Org: User:
Start: 11/30/10 End: 04/30/11 Due: 04/30/12

Activated Recombinant Human Factor VII Following Cardiac Bypass Surgery for Paediatric Congenital Heart Disease

Phase: N/A Priority: Normal
NCT ID: NCT01562574 Org: User:
Start: 01/31/02 End: 08/31/04 Due: 08/31/05

A Multiple Dose Study Investigating Pharmacokinetics and Pharmacodynamics of Subcutaneous NNC0363-0845 in Participants With Type 1 Diabetes Pharmacokinetics and Pharmacodynamics: How Insulin NNC0363-0845 is Transported Throughout the Body and How It Works

Phase: N/A Priority: Normal
NCT ID: NCT05134987 Org: User:
Start: 12/01/21 End: 05/06/22 Due: 05/06/23

A Research Study to See How Well CagriSema Helps People in China With Excess Body Weight Lose Weight

Phase: N/A Priority: Normal
NCT ID: NCT05996848 Org: User:
Start: 08/15/23 End: 02/22/25 Due: 02/22/26